Subscribe

Hemolytic Uremic Syndrome Secondary to Chemotherapy

Purpose:

To determine if a patient has developed a hemolytic uremic syndrome (HUS) secondary to chemotherapy.

Specialty:

Hematology Oncology
Nephrology, Urology, Obstetrics & Gynecology, Pedatrics, Genetics
Clinical Pharmacology & Toxicology

Objective:

adverse effects

ICD-10:

T45.1

Description:

The hemolytic uremic syndrome (HUS) may be caused by chemotherapy with certain chemotherapeutic agents. Prompt diagnosis is important to minimize significant morbidity and mortality.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone